Clinical Inertia in Diabetes: Is it Really a Problem?

Document Type

Conference Proceeding

Publication Date

1-28-2020

Publication Title

The Journal for Nurse Practitioners

Volume

16

Issue

2

First page number:

A14

Last page number:

A14

Abstract

Type 2 diabetes mellitus (T2DM) is a progressive disease where patients experience a decline in the beta cell function over time and require increasing therapeutic intervention to manage appropriately. The American Diabetes Association (ADA) Standards of Medical Care in Diabetes (2019)1 included new summary changes emphasizing the need for ongoing assessment and avoiding clinical inertia. The term clinical inertia has been defined as the failure of a health care provider to intensify or initiate therapy as indicated.2 Clinical inertia is seen as a complex interaction between patient and provider. It is dynamic and involves patients, providers, health care systems and barriers to practice and care.

Keywords

Clinical inertia; Type 2 diabetes mellitus; T2DM; Oral antidiabetic medications; Diabetes treatment

Disciplines

Endocrinology, Diabetes, and Metabolism | Medical Specialties | Medicine and Health Sciences

Language

English

UNLV article access

Search your library

Share

COinS